TITLE

Hemispherx Biopharma expands SARS initiative

PUB. DATE
December 2003
SOURCE
PharmaWatch: Biotechnology;December 2003, Vol. 2 Issue 12, p9
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
Introduces new drug delivery formats of Alferon N and Ampligen, lead compounds developed by Hemispherx Biopharma Inc. Clinical indications of the drugs; Description of Alferon N and Ampligen; Presentation of the clinical trial of the drugs.
ACCESSION #
13840386

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics